Literature DB >> 7325754

Disposition kinetics of furosemide in dogs.

M G El-Sayed, M Atef, A Y El-Gendi, S A Youssef.   

Abstract

In 12 experiments on 6 mongrel dogs, furosemide was given both orally and i.v. in a dose of 20mg/kg. Following i.v. injection, the blood concentration curve followed an open one-compartment model. The elimination half-lives after both oral and i.v. routes were nearly similar, i.e. 1.42 +10.13 and 1.13 +0.06 hours respectively. The apparent volume of distribution corresponded well to the total body water (about 60%), i.e. 69.64 +5.61 and 52.06+4.82% b.wt. after oral and i.v. routes respectively. The body clearance of this drug after i.v. and oral administration showed close values, i.e. 5.27 +0.19 and 5.96 +0.14 mg/kg(-1) min(-1) respectively. The systemic bioavailablity of furosemide after oral administration amounted to 77.13 +5.24% with a maximum blood conc. (Cmax.) of 22.73 +2.03 microgram/ml, 30 min after administration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7325754

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  3 in total

1.  Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls.

Authors:  Mark G Papich; Marilyn N Martinez
Journal:  AAPS J       Date:  2015-04-29       Impact factor: 4.009

2.  Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.

Authors:  V Chetboul; J-L Pouchelon; J Menard; J Blanc; L Desquilbet; A Petit; S Rougier; L Lucats; F Woehrle
Journal:  J Vet Intern Med       Date:  2017-10-04       Impact factor: 3.333

3.  Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016-2019).

Authors:  Camille Poissonnier; Sarra Ghazal; Peggy Passavin; Maria-Paz Alvarado; Solène Lefort; Emilie Trehiou-Sechi; Vittorio Saponaro; Alix Barbarino; Julia Delle Cave; Charlie-Rose Marchal; Boris Depré; Etienne Vannucci; Renaud Tissier; Patrick Verwaerde; Valérie Chetboul
Journal:  BMC Vet Res       Date:  2020-09-16       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.